Showing results (191-200 of 2,118) with videos related to
Sort By:
Pageof 212
Journal D'Urologie|January 1, 1983
[Primary retroperitoneal malignant germinal tumors in man]J L Amiel, J P Droz, P Ruffié, et al.Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1979
[The value of cis-diamminedichloroplatinum (cis-platinum) CDDP in the treatment of stage III and IV cancers of the ovary (author's transl)]J L Amiel, J P Droz, T Tursz, et al.Bulletin Du Cancer|April 1, 1997
Evaluation of long-term results of a modified VAB-6 chemotherapy regimen in a cohort of good-risk metastatic non seminomatous germ-cell tumorsS Culine, I Philippot, F Farhat, et al.Journal of Surgical Oncology|March 1, 1996
Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumorsS Culine, C Theodore, F Farhat, et al.Journal of Biological Response Modifiers|December 1, 1990
Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinomaT Hercend, F Farace, D Baume, et al.Bulletin Du Cancer|January 1, 1988
Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicityM Ghosn, P Carde, B Leclerq, et al.American Journal of Clinical Oncology|April 1, 1997
Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumorsS Culine, C Théodore, M Bekradda, et al.Journal D'Urologie|January 1, 1980
[Cis-diamminated-dichloroplatinum (CDDP) in the chemotherapy of testicular dysembryomas and choriocarcinomas (author's transl)]J L Amiel, J P Droz, T Tursz, et al.Cancer Research|March 8, 2000
A novel SMAD4 gene mutation in seminoma germ cell tumorsM Bouras, E Tabone, J Bertholon, et al.American Journal of Clinical Oncology|October 1, 1994
Hepatocellular carcinoma during hormonotherapy for prostatic cancerJ Kattan, A Spatz, S Culine, et al.Pageof 212